Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT05955092
Brief Summary:
The goal of this observational study is to test the application value of 3D bioprinting technology in personalized treatment of pancreatic cancer.
The main questions it aims to answer are:
* Can 3D bioprinting technology be successfully applied to establish preclinical models of pancreatic cancer?
* Can 3D bioprinted preclinical models of pancreatic cancer be applied to personalized treatment of pancreatic cancer?
Participants will have tumor tissue collected to extract primary tumor cells for the establishment of in vitro preclinical models, which will be used for drug sensitivity testing.
Study:
NCT05955092
Study Brief:
Protocol Section:
NCT05955092